Skip to content

Clinical trials

Completed Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Status: Completed Country / region: Norway Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20043
20054
20065
20073
20085
20093
20106
20117
20125
20135
20142
20157
20163
20175
20185
20193
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital12
Norwegian University of Science and Technology10
AstraZeneca5
Novartis Pharmaceuticals5
Sykehuset Innlandet HF4
Clavis Pharma3
GlaxoSmithKline2
Haukeland University Hospital2
Lytix Biopharma AS2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms75
Breast Neoplasms8
Melanoma6
Pain6
Prostatic Neoplasms5
Diabetes Mellitus4
Neoplasm Metastasis4
Recurrence4
Triple Negative Breast Neoplasms3
Adenocarcinoma2

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.